MATERIALS AND METHODS USEFUL FOR TREATING GLIOBLASTOMA
申请人:Ohio State Innovation Foundation
公开号:EP2919759A1
公开(公告)日:2015-09-23
COMBINATION THERAPY OF FRACTIONATED RADIATION AND SAPC-DOPS FOR THE TREATMENT OF TUMORS
申请人:University of Cincinnati
公开号:EP3697413A1
公开(公告)日:2020-08-26
sGCalpha1 Inhibiting Compositions, and Methods of Treatment of Cancers Therewith
申请人:The University of Toledo
公开号:US20140088023A1
公开(公告)日:2014-03-27
The present invention provides materials and methods useful to treat various sGCα1-expressing cancers. Materials include peptides which interfere with sGCα1's pro-survival functions, thereby resulting in apoptosis of sGCα1-expressing cells. In addition, the present invention provides screening assays, diagnostic assays, methods to prognose, methods to treat, and kits.
Materials and Methods Useful for Treating Glioblastoma
申请人:OHIO STATE INNOVATION FOUNDATION
公开号:US20150290300A1
公开(公告)日:2015-10-15
The present invention provides compositions and methods useful for treating cancers such as glioblastoma. SapC-DOPS was found to be synergistically effective at inducing cell death when administered in conjunction with rapamycin. SapC-DOPS/rapamycin combination therapy allows physicians to give lower doses of each drug and achieve better therapeutic efficacy. The compositions also allow for less toxicity and fewer off-target effects. Related methods and materials are also provided herein.
Materials and Methods Useful For Treating Glioblastoma
申请人:Ohio State Innovation Foundation
公开号:US20170340715A1
公开(公告)日:2017-11-30
The present invention provides compositions and methods useful for treating cancers such as glioblastoma. SapC-DOPS was found to be synergistically effective at inducing cell death when administered in conjunction with rampamycin. SapC-DOPS/rapamycin combination therapy allows physicians to give lower doses of each drug and achieve better therapeutic efficacy. The compositions also allow for less toxicity and fewer off-target effects. Related methods and materials are also provided herein.